# FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer-gene programs in basal-like breast cancer. (K Kumegawa*, L Yang*, et al., Frontiers in Oncology, 2023)

## DOI :  10.3389/fonc.2023.1156111
### Thank you for visiting our publication page.  
### Main R codes are availble. Please cite if our work helps you.
### All sequencing data is deposited in [GEO](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230119)

![](https://github.com/KoheiKumegawa/BasalBC_GMM/blob/main/figure1_v3.png)
